OCEANIC PHARMA
Ado-Trastuzumab Emtansine

Ado-Trastuzumab Emtansine

Send Inquiry

Ado-trastuzumab emtansine is approved to treat:

  • Breast cancer that is HER2 positive and has metastasized (spread to other parts of the body). It is used in patients who have already been treated with trastuzumab and a taxane. It is also used in these patients if the cancer recurs (comes back) after adjuvant therapy.